Source link : https://newshealth.biz/health-news/long-term-givinostat-data-reinforce-safety-profile-in-duchenne-muscular-dystrophy/
(MedPage Today) — SAN FRANCISCO — Givinostat (Duvyzat) had a manageable long-term safety profile in Duchenne muscular dystrophy, data from an open-label extension study suggested. Most treatment-emergent adverse events (TEAEs) were mild to… Source link : https://www.medpagetoday.com/meetingcoverage/aanem/118270 Author : Publish date : 2025-11-01 22:00:00 Copyright for syndicated content belongs to the linked Source.
The post Long-Term Givinostat Data Reinforce Safety Profile in Duchenne Muscular Dystrophy first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-01 22:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8